Specialist, Accounts Payable jobs in United States
cer-icon
Apply on Employer Site
company-logo

Arrowhead Pharmaceuticals · 17 hours ago

Specialist, Accounts Payable

Arrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative drugs for diseases with a genetic basis. They are seeking an Accounts Payable Specialist to assist in processing disbursements and support the Accounting Team in various financial tasks.

BiotechnologyHealth CareNanotechnologyPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Verify and process invoices
Research and address invoice related issues with Purchasing team, requestors, vendors, and others
Create Check, ACH and Wire payment files
File AP documents
Assist in system implementations
Assist in processing Concur expense reports for Travel & Expense reimbursements
Assist in the year-end preparation of 1099s
Prepare Accounts payable reports as needed
Ad hoc AP-related projects

Qualification

Accounts PayableMicrosoft OfficeAutomated workflow ERPConcur expense reportingCommunication skillsTime managementOrganizational skillsAttention to detail

Required

Business Degree or at least 2 years of relevant experience
Ability to gather, analyze and interpret information for completeness and accuracy; excellent attention to detail; and, excellent organizational skills
Proficient in Microsoft Office suite
Strong communication skills (oral & written); ability to effectively interact with others at all levels – within and outside of finance
Flexibility to put in extra hours during critical times such as month, quarter, and year-end close cycles
Strong time management with the ability to work independently and in a group setting

Preferred

Experience with an automated workflow ERP System, Microsoft D365 is a plus
Experience with Concur expense reporting

Benefits

Competitive salaries
Excellent benefit package

Company

Arrowhead Pharmaceuticals

twittertwittertwitter
company-logo
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

Funding

Current Stage
Public Company
Total Funding
$2.45B
Key Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M

Leadership Team

leader-logo
Christopher Anzalone
President and Chief Executive Officer
Company data provided by crunchbase